Skip to search formSkip to main contentSkip to account menu

cyclophosphamide/doxorubicin protocol

Known as: AC, ACE, CTX/DOX 
National Institutes of Health

Related topics

Related topics

7 relations
Adriamycin-Cytoxan RegimenCAE protocolCDE protocol-cyclophosphamide/doxorubicin/etoposideDoxorubicin

Broader (2)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Antimicrobial activity of food-compatible plant extracts and chitosan against naturally occurring micro-organisms in tomato juice.
BACKGROUND Chitosan (AC) and five hydroalcoholic extracts from Lithospermum erythrorhizon (SE), Rheum palmatum (RE), Thymus… 
2009
2009
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial…
BACKGROUND This randomized, multicenter, phase III trial compared doxorubicin plus cyclophosphamide (AC), single-agent docetaxel… 
Highly Cited
2008
Highly Cited
2008
Combining long-range transport and bioaccumulation considerations to identify potential Arctic contaminants.
The identification of potential Arctic contaminants requires an assessment of both the long-range transport and the… 
Highly Cited
2007
Highly Cited
2007
A 60 $\mu$W 60 nV/$\surd$Hz Readout Front-End for Portable Biopotential Acquisition Systems
There is a growing demand for low-power, small-size and ambulatory biopotential acquisition systems. A crucial and important… 
2007
2007
Enhanced absorption of anthocyanins after oral administration of phytic acid in rats and humans.
Many studies on the bioavailability of polyphenols have been reported. However, the relative urinary excretions of AC are also… 
Highly Cited
2005
Highly Cited
2005
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
PURPOSE Dose-dense, every-2-week adjuvant chemotherapy using doxorubicin/cyclophosphamide (AC; 60/600 mg/m2 every 2 weeks x four… 
Highly Cited
2005
Highly Cited
2005
E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer
512 Background: AT is one of the most active regimens in ABC (response rates=44–83%). Methods: A Phase III Intergroup trial was… 
2005
2005
Efficacy of ACE‐inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study
Background  The efficacy of ACE‐inhibitors in decreasing microalbuminuria and proteinuria has been reported in a few patients… 
Highly Cited
2001
Highly Cited
2001
Heat-cured acrylic resin repaired with microwave-cured one: bond strength and surface texture.
This study evaluated the influence of chemical surface treatments in the repair strength of a heat-cured acrylic resin (Lucitone… 
Highly Cited
1967
Highly Cited
1967
Biosynthetic pathways from acetate to natural products
  • F. Lynen
  • Pure and applied chemistry. Chimie pure et…
  • 1967
  • Corpus ID: 18588543
Abstract 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)